BioSpace News Archive

Genetown

Moderna’s mRNA Zika Vaccine Data Supports COVID-19 Vaccine Approach

Moderna’s mRNA Zika vaccine data is becoming helpful in the development of the COVID-19 vaccine. The company is using the elements to faster the process of producing the vaccine.

April 14, 2020
·
4 min read
·
Mark Terry
Business

GSK and Sanofi Join Forces to Develop a COVID-19 Vaccine

The two companies are eying the second half of this year to begin clinical trials on their combined project and, if the vaccine meets expectations, the companies said it could be available for use in the second half of 2021.

April 14, 2020
·
3 min read
·
Alex Keown
Drug Development

BeiGene’s Checkpoint Inhibitor Hits the Mark in Phase III Lung Cancer Study

A preliminary analysis of late-stage trial data shows that BeiGene’s investigational checkpoint inhibitor tislelizumab is hitting the mark as a potential first-line treatment in patients with non-squamous non-small cell lung cancer.

April 14, 2020
·
2 min read
·
Alex Keown
Business

Blackstone and Alnylam Partner in RNAi Deal Worth up to $2 Billion

“Blackstone is uniquely positioned to provide customized, one-stop-shop financing solutions at scale while establishing development collaborations with the world’s leading biotech companies,” said Nicholas Galakatos, global head of Blackstone Life Sciences.

April 14, 2020
·
3 min read
·
Mark Terry
Business

New NIH Research Links Brain Glucose Metabolism and Neuroinflammation to Alzheimer’s Disease

The investigators assayed the levels and analyzed the expression patterns of more than 3,000 proteins in brain and cerebrospinal fluid samples collected at centers across the U.S.

April 14, 2020
·
3 min read
·
Mark Terry
BioCapital

WHO: More than 70 COVID-19 Vaccines are in Development, Three in Clinical Trials

It’s likely that more companies and universities will add additional assets as time goes on.

April 14, 2020
·
3 min read
·
Alex Keown
Business

Origin Ramps Up Production of 3D-Printed Test Swabs

Origin, a 3D printing specialist for medical devices, just completed clinical trials and validation of its 3D-printed nasopharyngeal swabs for use in COVID-19 test kits. It is scaling up production and accepting orders to manufacture millions of the swabs.

April 14, 2020
·
5 min read
·
Gail Dutton
Business

Cerevance Nabs $45 Million in Funding to Support CNS Disease Research

Cerevance secured $45 million in a Series B financing round to support the development of its therapeutics for central nervous system diseases, including Alzheimer’s and Parkinson’s disease.

April 14, 2020
·
3 min read
·
Alex Keown
Lone Star Bio

Study Shows Snake Venom Can Help Uncover Detailed Shape of Critical Protein in Muscle Contractions

The protein, called a nicotinic receptor, has been a challenge to study since it sits in the cell’s membrane.

April 14, 2020
·
2 min read
·
Michelle Brugioni
Drug Development

Biopharma Update on the Novel Coronavirus: April 14

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 14, 2020.

April 14, 2020
·
6 min read
·
BioSpace Editorial Staff